Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient’s undergoing urologic oncology surgery: a systematic review
Nathan A. Brooks(Eli Lilly (United States)), Stephen B. Williams(Cedars-Sinai Medical Center), Justin Collins(University College Hospital), James W.F. Catto(University of Sheffield), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Andrea Kokorovic(Dalhousie University), Hooman Djaladat(University of Southern California), Siamak Daneshmand(Unknown), Peter C. Black(University of British Columbia), James J. Douglas, John McGrath(Royal Devon & Exeter NHS Foundation Trust), Wassim Kassouf(McGill University)
Cited by 43
Related Papers
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688